Bettersize Exhibits Particle Analysis Tech in New Orleans
The company is showcasing its latest diagnostic systems for drug formulation at the AAPS 2026 PharmSci 360 conference.
Updated on Oct. 28, 2026 in Biotech
Bettersize Instruments is displaying its advanced particle characterization technologies at the AAPS 2026 PharmSci 360 conference in New Orleans. The company is highlighting systems designed to provide structural insights for pharmaceutical professionals.
Why it matters
These tools offer critical data on active pharmaceutical ingredients, drug stability, and particle morphology to improve formulation precision. The technology allows researchers to better understand how specific substances behave at the molecular level.
The BeNano 180 Zeta Max operates with a minimum sample volume of 3 μL using measurement angles of 173° and 90°. Meanwhile, the Bettersizer 2600 Plus utilizes laser diffraction and dual-camera imaging to cover a size range from 0.02 μm to 3,500 μm.
The players
Bettersize Instruments
This company specializes in the development and manufacturing of particle size analysis and characterization equipment for various industrial and scientific applications.
AAPS 2026 PharmSci 360
This is an annual scientific conference focused on the latest advancements in pharmaceutical research, drug development, and delivery systems.
The details
Bettersize Instruments is operating out of booth 1328, where it is demonstrating three primary systems: the BeNano 180 Zeta Max, the Bettersizer 2600 Plus, and the BeVision D3. These machines employ dynamic light scattering and phase analysis to measure nanoparticle size, molecular weight, and particle shape.
Timeline
The AAPS 2026 PharmSci 360 conference runs in New Orleans from October 25 to October 28, 2026.
The Tech Race
The exhibition follows the established industry standard set by the AAPS PharmSci 360 conference for showcasing analytical precision. This integration of advanced imaging and light scattering tools reflects the ongoing shift toward higher-resolution particle characterization in drug development.
These analytical tools enable researchers to develop more stable and effective drugs by improving the precision of nanoparticle formulations. Professionals in the field can utilize these specific systems to streamline their laboratory workflows and improve data accuracy.
The takeaway
Advanced particle analysis remains a cornerstone of ensuring the safety and efficacy of new drug formulations in the pharmaceutical industry. Researchers looking to improve stability should focus on adopting systems that integrate both size measurement and real-time physical imaging.
Further reading
Learn more about the latest developments in Biotech to stay updated on emerging pharmaceutical research tools.
Source note: This article includes information reported by Selectscience.
